Alain Chapel is the Principal Investigator of the Laboratory of Gene and Cell Therapy for the Institute of Radioprotection and Nuclear Safety. He developed gene therapy of nonhuman primate to protect against side effects of radiation. He has a strong implication in regenerative medicine. He collaborates with clinicians to develop new strategies for treatment of patients after radiation accidents or radiotherapy overexposures. Chapel has published more than 60 papers in this area. In the recent year, he got some important success in several patients? treatments using stem cells. In animal model, he can propose mechanisms to explain the successfulness of these new therapeutically correction approaches.
Biography Updated on 4 April 2014